105 related articles for article (PubMed ID: 18032936)
1. HIV-infected Rwandan women have a high frequency of long-term survival.
Peters PJ; Karita E; Kayitenkore K; Meinzen-Derr J; Kim DJ; Tichacek A; Allen SA
AIDS; 2007 Nov; 21 Suppl 6():S31-7. PubMed ID: 18032936
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
3. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.
Lavreys L; Baeten JM; Chohan V; McClelland RS; Hassan WM; Richardson BA; Mandaliya K; Ndinya-Achola JO; Overbaugh J
Clin Infect Dis; 2006 May; 42(9):1333-9. PubMed ID: 16586394
[TBL] [Abstract][Full Text] [Related]
4. The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up.
Rangsin R; Piyaraj P; Sirisanthana T; Sirisopana N; Short O; Nelson KE
AIDS; 2007 Nov; 21 Suppl 6():S39-46. PubMed ID: 18032937
[TBL] [Abstract][Full Text] [Related]
5. Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up.
Glynn JR; Sonnenberg P; Nelson G; Bester A; Shearer S; Murray J
AIDS; 2007 Mar; 21(5):625-32. PubMed ID: 17314525
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
7. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
[TBL] [Abstract][Full Text] [Related]
8. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
9. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
[TBL] [Abstract][Full Text] [Related]
10. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
Geretti AM; Smith C; Haberl A; Garcia-Diaz A; Nebbia G; Johnson M; Phillips A; Staszewski S
Antivir Ther; 2008; 13(7):927-36. PubMed ID: 19043927
[TBL] [Abstract][Full Text] [Related]
11. Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993.
Leroy V; Msellati P; Lepage P; Batungwanayo J; Hitimana DG; Taelman H; Bogaerts J; Boineau F; Van de Perre P; Simonon A
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):415-21. PubMed ID: 7600110
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
Chiao EY; Giordano TP; Richardson P; El-Serag HB
J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
14. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
[TBL] [Abstract][Full Text] [Related]
17. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda.
Lutalo T; Gray RH; Wawer M; Sewankambo N; Serwadda D; Laeyendecker O; Kiwanuka N; Nalugoda F; Kigozi G; Ndyanabo A; Bwanika JB; Reynolds SJ; Quinn T; Opendi P
AIDS; 2007 Nov; 21 Suppl 6():S15-9. PubMed ID: 18032934
[TBL] [Abstract][Full Text] [Related]
18. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
19. Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries.
Achhra AC; Phanuphak P; Amin J
Curr Opin HIV AIDS; 2011 Jul; 6(4):258-65. PubMed ID: 21546834
[TBL] [Abstract][Full Text] [Related]
20. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
